Views & Analysis Closing the feedback loop to drive patient experience improv... Is collecting near real time data the key to unlocking improvements in patient experience and national benchmarking?
Views & Analysis How a lack of mental health diagnosis is affecting young men As lockdown gradually eases, things are starting to look up but the lasting impact COVID-19 has had on our wellbeing remains.
Views & Analysis Why relationships are key in rare disease patient engagement Real-world data is a vital part of rare disease drug development, but to get a true picture of patients’ unmet needs pharma should take a broader view of their lived experiences, says Xperi
Views & Analysis Not just COVID-19 vaccines: 5 things that cause blood clots Reports of COVID-19 vaccinations causing blood clots has caused alarm in the general population.
Views & Analysis Growing up different and not knowing why: My experience of r... Protracted diagnostic odysseys don’t only block access to rare disease treatments, they also leave people facing emotional turmoil all alone.
Views & Analysis Cytisinicline - the solution to stop smoking? Whether present in electronic or combustible cigarettes, nicotine is a highly addictive substance.
News GBL joins CVC in €10.7bn takeover bid for Recordati A consortium of investors has made a €10.7bn offer to take Italian pharma Recordati private, but some analysts are sceptical the deal will go through.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.